Skip to content

Revvity RVTY Other current assets

Other current assets at other companies

Idexx Laboratories logo
Idexx LaboratoriesIDXX
$267.6M+16.3%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$1.43B+24.5%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
WAT
Waters CorporationWAT
Agilent Technologies logo
Agilent TechnologiesA
Roivant Sciences logo
Roivant SciencesROIV

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's other current assets?
Revvity (RVTY) reported other current assets of $189.11M in Q1 2026.
How has Revvity's other current assets changed year-over-year?
Revvity's other current assets increased by 4.1% year-over-year, from $181.59M to $189.11M.
What is the long-term trend for Revvity's other current assets?
Over 5 years (2020 to 2025), Revvity's other current assets has grown at a 3.2% compound annual growth rate (CAGR), from $167.21M to $195.72M.